Skip to content
Business Company News, Medical Health Aged Care

Hola Health announces AUD4.5M venture investment to revolutionise on-demand healthcare in Australia

Hola Health 2 mins read

Perth, Australia – Hola Health, a leading Australian telehealth and medicine delivery company, has announced it has closed a AUD4.5 million Pre-Series A venture funding round led by M8 Ventures. This investment marks a pivotal moment in Hola Health's mission to revolutionise 'on-demand' healthcare in Australia, providing fast, value-for-money care within 15 minutes, 24 hours a day, 7 days a week.

The round was led by early-stage tech venture fund M8 Ventures with follow-on capital from existing investors.

Lenin Rajendran, Cofounder and CEO of Hola Health, expressed his enthusiasm for the partnership, stating, "This investment is not just a financial boost but a strong vote of confidence in our vision to make primary healthcare accessible and immediate for all Australians. We're now set to fast-track our growth, bringing our services to even more people across the country, and preparing for our first international markets."

Wait times are too long, with close to half of all Australian patients seeing a GP for urgent care forced to wait 24 hours or more for treatment, and a quarter of all patients waiting longer for appointments than they feel is acceptable. And the issue is more pronounced in regional areas, compounding existing inequities between urban and rural populations. 

Hola Health's success has been recognized with its recent recognition in the 2023 AFR Fast Starters list, highlighting its rapid growth and the increasing demand for accessible healthcare solutions. 

Emily Rich, General Partner at M8 Ventures, will be joining the Hola Health board. "We are excited to lead this round of investment for Hola Health. Their innovative approach to on-demand healthcare, combined with their impressive growth and commitment to excellence, aligns perfectly with our investment philosophy. We look forward to supporting Hola Health as they continue to expand and redefine healthcare accessibility in Australia," said Rich.

The investment will be used to scale Hola Health's operations, expanding its reach to more consumers and corporate customers. The company has already established partnerships with HealthEngine, MedAdvisor, TerryWhiteChemmart, and features in the Uber Eats and DoorDash pharmacy online marketplaces, demonstrating its commitment to integrating healthcare services seamlessly into Australians' lives.

Hola Health raised a seed round in 2023 led by FundWA.

About us:

**About Hola Health**

Hola Health is an on-demand telehealth and medicine delivery business revolutionising healthcare in Australia. With a focus on fast, value-for-money care, Hola Health offers consultations and medicine delivery within 15 minutes, 24/7. Founded by Lenin Rajendran (CEO), Thiru Rajendran (CTO) and Dr Vishnu Gopalan (Chief Medical Officer), Hola Health is on a mission to make healthcare accessible to all Australians, leveraging technology to overcome the challenges of long wait times and limited access to primary healthcare services. More about Hola Health at 

**About M8 Ventures**


M8 Ventures is a Sydney, Australia based venture fund manager cofounded by Emily Rich and Alan Jones and backed by some of Australia’s most-respected tech startup industry professionals. M8 Ventures backs world-class product-focused startups based in Australian and New Zealand. More about M8 Ventures at  


Contact details:

For media enquiries, please contact Alan Jones at M8 Ventures at or +61414987069


More from this category

  • Government NSW, Medical Health Aged Care
  • 12/07/2024
  • 12:39
MEDIA RELEASE - Network of Alcohol & Other Drug Agencies


12 July 2024 The forthcoming NSW Drug Summit is an opportunity to shelve outdated drug policies that have failed to deliver better health andwellbeing outcomes for individuals and their families. That’s the verdict from the peak organisation for the non-government drug and alcohol sector in NSW, the Network of Alcohol and other Drugs Agencies (NADA). NADA today welcomed the Government’s confirmation the NSW Drug Summit will be held over two days in regional NSW in October, and in Sydney on 4th and 5th December, as well as consultations about the Terms of Reference and other matters ahead of this. NADA…

  • Contains:
  • Medical Health Aged Care
  • 12/07/2024
  • 09:00
National Hypertension Taskforce - Australian Cardiovascular Alliance and Hypertension Australia

Australian Hypertension Taskforce unveils Roadmap to transform high blood pressure control and reduce preventable deaths

Raised blood pressure (BP), also known as hypertension, is a ‘silent killer’ and the leading cause of death in Australia, where it contributes to more than 25,000 deaths each year. It is also the leading risk factor for death from stroke, heart disease, kidney disease, and dementia, yet 68% of Australians with hypertension are uncontrolled. In response to this pressing issue, a Call to Action was published in 2022, leading to the establishment of the National Hypertension Taskforce, launched by Mark Butler MP, Minister for Health and Aged Care. The National Hypertension Taskforce, led by the Australian Cardiovascular Alliance and…

  • Business Company News
  • 12/07/2024
  • 06:00


The new MYOB Business Monitor: SME Performance Indicator, released by MYOB today at the Australian Conference of Economists, reveals the small business sector is…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.